Loading TrenasCycles…
Peptides / investigational recovery peptide
Body Protection Compound 157
BPC-157 is marketed for tendon, muscle and gut recovery. Most evidence comes from animal work, so reliable healing effects in people are still unproven. A two-person safety study did not test injury recovery. Unknown long-term effects, possible immune reactions and inconsistent injection quality are the main concerns.
Most positive findings are animal studies. A pilot involving only two healthy adults cannot establish effectiveness, broad safety or long-term risk.
No established clinical efficacy or standardized product; extremely limited human safety evidence; sterility, contamination and mislabeling risks; unknown long-term effects.
No validated monitoring program can make an unapproved product safe; assess injection complications and unexplained systemic symptoms clinically.
No standardized approved product, route or clinical indication. Products sold for human use are unapproved.
Other aliases: Body Protection Compound 157 · BPC 157 · BPC157
Reported short-term observations after intravenous exposure in two participants.
Two people cannot establish clinical effectiveness, broad safety, an approved route or long-term risk.
Original source ↗